
The highly selective 5-HT2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset
Keywords: روان پریشی; EMD-281,014; Parkinson's disease; Psychosis; Dyskinesia; Pharmacokinetics; Marmoset;